Cover Story
CEOCFO
Interview
Index &
Quotes
CEOCFO
Current Issue
Future
Features
Monthly
Analyst
Industry
Review
Analyst
Interviews
and Reports
Corporate
Financials
Archived
CEOCFO
Interviews
About
CEOCFO
interviews.com
Contact
& Ordering |
Medwave - changing the standard of care
in blood pressure monitoring with their Vasotrac® and Vasotrax™ products
Healthcare
Medical Equipment & Supplies
NASD: MDWV
Medwave, Inc.
Timothy O’Malley
President and
Chief Executive Officer
Interview conducted by:
Walter Banks
Co-Publisher
CEOCFOinterviews.com
May 2002
Company Profile:
Medwave, Inc. develops, manufactures and sells a continuous, non-invasive direct
arterial blood pressure monitoring device. Its
Vasotrac® APM 205A system monitors patient blood pressure through a sensor placed over
the radial artery in the wrist. The wrist piece applies pressure to the artery, and the
sensor reads the blood pressure and produces waveforms every 15 heartbeats. It does not
require a cuff, which enhances patient comfort, contains no mercury and stores up to 900
readings. It is marketed to healthcare
professionals, in hospitals, outpatient surgery centers and higher-end cardiology offices.
New features and products include Pediatric capabilities, High Motion Tolerant Software,
and the NIA V-Line Interface Package. The NIA V-Line transforms Medwave's Vasotrac®
continuous, noninvasive, blood pressure monitor and allows it to emulate an invasive
arterial catheter. The NIA V-Line connects Vasotrac® to any patient monitor for true
integration. The company has an OEM supply agreement with Japan-based Nihon Kohden to
develop a module of Vasotrac® for use in Nihon Kohden's larger systems.
Medwave has also developed a handheld version called the Vasotrax™, which is targeted towards the nursing community, the physician office
market and even some of the higher-end oral surgery dental market.
It can be clipped to a belt or scrubs. With a
single charge, you can take approximately 200 readings. At the end of a shift, the unit
can be placed in a Vasoport-4 recharging station. The stored measurements will offer
future capabilities, allowing the readings to be downloaded into a computer-based system
while the unit is recharging. On the next shift, it is ready to go again. Vasoports are
available in two, four and eight bay configurations. Two eight-bay units may be configured
to create a 16-bay unit.
Interview Highlights:
- When was Medwave incorporated?
- What was their initial goal and when did they come out with their flagship product?
- What is their flagship product and what does it offer to the clinical community?
- What other product is it compared to and what are its advantages?
- How many products do they have on the market today?
- Is one of their products a hand-held?
- Where would you find their products being used?
- Do they envision either of their products being sold to the consumer?
- How big is the marketplace?
- Which of their products offers the greatest revenue potential?
- How long has the CEO been with Medwave?
- Are their any risks involved with using their products?
- How do you use their products?
- What is the accuracy of their products?
- Does their products offer cost savings to the healthcare community?
- What has been their market penetration?
- Can their product be interfaced into large patient monitoring systems that may be part
of the infrastructure of the hospital already?
- Is their product applicable to the pediatric environment?
- Has their products been endorsed by anyone?
- Is either of their products useful to paramedics or an EMT?
- Is the accuracy of their product affected by external noise or motion?
- Are their products being marketed globally?
- In building out market penetration, will it be necessary to build out your own sales
force or is it more in developing partnerships?
- Who is their major global partner?
- Can their products plug into other systems or is it strictly a stand-alone?
- What is their next challenge in the global marketplace, what other countries will they
look at?
- What is their marketing and sales strategy?
- How has their product pipeline been built?
- Are they still dedicating a great deal of their revenues to R&D?
- How does their patent protection currently stand?
- What is their revenue model?
- Do they have the cash or credit to continue to build out their organization?
To
receive a copy of this highly informative interview, left click here: Contact & Ordering
disclaimer |
